Overview
- 40 inspections across 38 sites are on record.
- 92 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-25.
At a glance
Inspections
40
Sites
38
Observations
92
Career since
Oct 2020
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| LeMaitre Vascular, Inc. | 25 Jun 2026 | Medical Devices & Rad Health | View 483 → |
| Me Luna GmbH | 26 Feb 2026 | Medical Devices & Rad Health | View 483 → |
| ALPES CN SAS | 19 Feb 2026 | Medical Devices & Rad Health | |
| Cellpack Ag | 12 Feb 2026 | Medical Devices & Rad Health | |
| Speciality Pharma Manufacturing, LLC | 6 Nov 2025 | Medical Devices & Rad Health |
Sites inspected
LeMaitre Vascular, Inc.North Brunswick, United States1 insp.
Me Luna GmbHHaundorf, Germany1 insp.
ALPES CN SASReignier-Esery, France1 insp.
Cellpack AgVillmergen, Switzerland1 insp.
Speciality Pharma Manufacturing, LLCCarlstadt, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
William R Chang5 shared
Frank J Marciniak3 shared
Monica L Gutierrez3 shared
Melissa A Zuppe3 shared
Jaro P Perera2 shared
Shirley S Wen2 shared
Jonathan Ho2 shared
Naakesh N Gomanie2 shared
David H Smith2 shared
Rosanna M Goodrich1 shared
Full investigator report
Get the verbatim findings behind Matthew W Kyle's 92 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site